USD 0.12
(-2.8%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 | 17.31 Million USD | 26.85% |
2023 | 13.65 Million USD | 347.01% |
2022 | 3.05 Million USD | 676.22% |
2021 | -530.02 Thousand USD | 32.71% |
2020 | -787.61 Thousand USD | -282.77% |
2019 | -205.76 Thousand USD | -122.67% |
2018 | -92.41 Thousand USD | -101.68% |
2017 | -45.82 Thousand USD | 0.0% |
2016 | - USD | 0.0% |
2015 | - USD | 0.0% |
2014 | - USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q3 | 4.36 Million USD | 7.76% |
2024 Q4 | 3.2 Million USD | -26.57% |
2024 Q1 | 3.83 Million USD | -10.69% |
2024 Q2 | 4.04 Million USD | 5.55% |
2024 FY | 17.31 Million USD | 26.85% |
2023 FY | 13.65 Million USD | 347.01% |
2023 Q3 | 3.56 Million USD | 17.29% |
2023 Q2 | 3.03 Million USD | 9.96% |
2023 Q1 | 2.76 Million USD | -9.81% |
2023 Q4 | 4.29 Million USD | 20.58% |
2022 Q2 | -20.18 Thousand USD | -338.4% |
2022 Q4 | 3.06 Million USD | 66230.94% |
2022 FY | 3.05 Million USD | 676.22% |
2022 Q1 | 8466.00 USD | 0.0% |
2022 Q3 | 4615.00 USD | 122.87% |
2021 FY | -530.02 Thousand USD | 32.71% |
2021 Q2 | - USD | 0.0% |
2021 Q1 | - USD | 0.0% |
2021 Q4 | - USD | 0.0% |
2021 Q3 | - USD | 0.0% |
2020 Q2 | - USD | 0.0% |
2020 FY | -787.61 Thousand USD | -282.77% |
2020 Q4 | - USD | 0.0% |
2020 Q3 | - USD | 0.0% |
2020 Q1 | - USD | 0.0% |
2019 Q1 | - USD | 0.0% |
2019 FY | -205.76 Thousand USD | -122.67% |
2019 Q4 | - USD | 0.0% |
2019 Q3 | - USD | 0.0% |
2019 Q2 | - USD | 0.0% |
2018 Q1 | - USD | 0.0% |
2018 Q3 | - USD | 0.0% |
2018 Q4 | - USD | 0.0% |
2018 FY | -92.41 Thousand USD | -101.68% |
2018 Q2 | - USD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q3 | - USD | 0.0% |
2017 Q2 | - USD | 0.0% |
2017 Q4 | - USD | 0.0% |
2017 FY | -45.82 Thousand USD | 0.0% |
2016 Q1 | - USD | 0.0% |
2016 Q4 | - USD | 0.0% |
2016 Q3 | - USD | 0.0% |
2016 FY | - USD | 0.0% |
2016 Q2 | - USD | 0.0% |
2015 Q2 | - USD | 0.0% |
2015 Q4 | - USD | 0.0% |
2015 Q3 | - USD | 0.0% |
2015 FY | - USD | 0.0% |
2015 Q1 | - USD | 0.0% |
2014 Q2 | - USD | 0.0% |
2014 Q4 | - USD | 0.0% |
2014 FY | - USD | 0.0% |
2014 Q3 | - USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
China Pharma Holdings, Inc. | -504.88 Thousand USD | 3530.115% |
cbdMD, Inc. | 14.97 Million USD | -15.626% |
cbdMD, Inc. | 14.97 Million USD | -15.626% |